A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.
Journal Information
Full Title: Int J Gen Med
Abbreviation: Int J Gen Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, General & Internal
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures: Drs. Chappell, Detke, and D’Souza are employees and stockholders of Eli Lilly and Company. Dr Wiltse is a former employee of Eli Lilly and Company. Dr Spaeth is a consultant to Allergan, Eli Lilly, Jazz, and Pierre Fabre Medicament, and is on the speaker bureaus of Eli Lilly and Pierre Fabre Medicament. Dr Bradley is a consultant for Eli Lilly, Pfizer, and Forest; has received grant/research support from the National Institutes of Health, the Agency for Healthcare Research and Quality, Eli Lilly, Pfizer, and the American Fibromyalgia Syndrome Association; has received honoraria from Eli Lilly, Pfizer, Forest, and the Society for Women’s Health Research; is a member of the speaker/advisory board for Pfizer; and has received royalties from UpToDate Rheumatology."
"This work was sponsored by Eli Lilly and Company and Boehringer Ingelheim GmbH. Trial Investigators were: Dr Gabriel Herrero-Beaumont, Fundación Jiménez Díaz; Dr Arturo Rodriguez De La Serna, Hospital Santa Creu I Sant Pau; Dr Cayetano Alegre De Miquel, Ciutat Sanitaria De La Vall De Hebron; Dr Juan Roberto Minguélez Sánchez, Hospital De Mostoles; Dr Javier Rivera Redondo, Instituto De Rehabilitación-Hospital Gregorio Marañón; Dr Roland Woerz (Office); Dr Wolfgang Bolten, Rheumaklinikum Wiesbaden-Zentrum Für Schmerztherapie; Dr Wolfgang Brueckle, Rheumaklinik Bad Nenndorg; Dr Gerhard Mueller-Schwefe (Office); Dr Wolfgang Molt (Practice); Dr Michael Ribbat (Office); Dr Walter Albrecht (Practice), Dr Michael Spaeth (Practice), Dr Olof Zachrisson, Gottfriesmottagningen; Dr Britt-Marie Öberg, Danderyds Sjukhus Rehabiliteringsmedicinska kliniken; Dr Jan Sorensen, Universitetssjukhuset Linkoping Smärt-och rehabcenter Smärtoch Rehabcenter; Dr Brian Hazleman, Addenbrookes Hospital; Dr Anthony D Woolf, Royal Cornwall Hospital; Dr Bruce Kirkham, Guys and St. Thomas Hospital Rheumatology Department; Dr Ashok Bhalla, Royal National Hospital For Rheumatic Diseases; Dr James R. Bellor, Columbia Medical Practice; Dr Laurence Bradley, University of Alabama at Birmingham; Dr Nicholas A. Bertini, Clinical Research Consultants, Inc.; Dr Mildred V. Farmer, Meridien Research; Dr H. S. Eugene Fung, Arthritis and Osteoporosis Clinic Of Central Texas; Dr Ronica Kluge, Clinical Physiology Associates, Clinical Study Center; Dr Andrew F. Leuchter, Neuropsychiatric Institute; Dr Lori Wynstock, Southern California Clinical Lab; Dr C Brendan Montano, Connecticut Clinical Trials Llc; Dr Paul K. Pickrell, Metaclin Research Inc.; Dr Steven Elliot, Medisphere Medical Research Center Llc; Dr Oscar Soto (Private); Dr Harris H. Mcilwain, Tampa Medical Group, P. A; Dr Craig M. Mccarthy, Pivotal Research Centers; Dr Siavash Nael, Neuropsychiatric Center; Dr Timothy R. Smith, Mercy Health Research."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025